Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
Saved in:
| Title: | Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia. |
|---|---|
| Authors: | Rautenberg C; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Stölzel F; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Röllig C; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Stelljes M; Department of Medicine A, University Hospital Münster, Münster, Germany., Gaidzik V; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Lauseker M; Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians-University, Munich, Germany., Kriege O; Department of Medicine III, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany., Verbeek M; Department of Medicine III, Technical University of Munich, Munich, Germany., Unglaub JM; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Krause SW; Department V for Internal Medicine, University Hospital Erlangen, Erlangen, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Neuerburg C; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany., Vucinic V; Leipzig: Department of Hematology and Cell Therapy, Medical Oncology, Hemostaseology, Leipzig, Germany., Jehn CF; Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Clinic St. Georg, Hamburg, Germany., Severmann J; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany., Wass M; Clinic and Policlinic for Internal Medicine IV, University Hospital Halle (Saale), Halle (Saale), Germany., Fransecky L; Departmenf for Internal Medicine II, University Schleswig-Holstein, Kiel, Germany., Chemnitz J; Gemeinschaftsklinikum Mittelrhein GGmbH, Koblenz, Germany., Holtick U; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Schäfer-Eckart K; Department of Internal Medicine V, Oncology and Hematology, Klinikum Nürnberg, Nürnberg, Germany., Schröder J; Clinic for Heaematology and Stem Cell Transplantation HELIOS Clinic Berlin-Buch GmbH, Berlin, Germany., Kraus S; Division of Hematology and Oncology, Department of Internal Medicine II, University of Würzburg, Medical Center, Würzburg, Germany., Krüger W; Clinic and Policlinic for Internal Medicine C, Hematology and Oncology, University of Greifswald, Greifswald, Germany., Kaiser U; Department of Hematology and Oncology, St. Bernward Krankenhaus, Hildesheim, Germany., Scholl S; Department of Internal Medicine II, Hematology and Oncology, University Hospital Jena, Jena, Germany., Koch K; Department of Medicine III, Technical University of Munich, Munich, Germany., Henning L; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Haas R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Alakel N; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Röhnert MA; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Sockel K; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Hanoun M; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany., Platzbecker U; Leipzig: Department of Hematology and Cell Therapy, Medical Oncology, Hemostaseology, Leipzig, Germany., Holderried TAW; Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany., Morgner A; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Sauer T; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Götze KS; Department of Medicine III, Technical University of Munich, Munich, Germany., Wagner-Drouet E; Department of Medicine III, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Schliemann C; Department of Medicine A, University Hospital Münster, Münster, Germany., Schetelig J; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Bornhäuser M; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany., Germing U; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany., Schroeder T; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine-University, Duesseldorf, Germany. Thomas.schroeder@uk-essen.de.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany. Thomas.schroeder@uk-essen.de., Middeke JM; Medizinische Klinik und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany. Janmoritz.middeke@ukdd.de. |
| Source: | Blood cancer journal [Blood Cancer J] 2021 Oct 04; Vol. 11 (10), pp. 164. Date of Electronic Publication: 2021 Oct 04. |
| Publication Type: | Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-021-00558-5 |
